Robert Clayton Alspach is named as a lobbyist on federal disclosure filings for 6 clients through Leavitt Partners, LLC. The most recent filing naming them posted in October 2026. Issues reported include Health Issues.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| ALLIANCE FOR MRNA MEDICINES | LEAVITT PARTNERS, LLC | Q3 2026 | Health Issues |
| SAVE RARE TREATMENTS TASK FORCE | LEAVITT PARTNERS, LLC | Q3 2026 | Health Issues |
| SICKLE CELL DISEASE PARTNERSHIP | LEAVITT PARTNERS, LLC | Q3 2026 | Health Issues |
| BAXTER HEALTHCARE | LEAVITT PARTNERS, LLC | Q3 2026 | Health Issues |
| ASSOCIATION OF CLINICAL RESEARCH ORGANIZATIONS | LEAVITT PARTNERS, LLC | Q1 2026 | Health Issues |
| GENOMIC ANSWERS FOR CHILDRENS HEALTH ALLIANCE (GACHA) | LEAVITT PARTNERS, LLC | Q1 2025 | Health Issues |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 4 | 1 |
| 2025 | 5 | 1 |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Robert Clayton Alspach. See the Capitol Clarity rankings and method.